Shuanghuanglian
Shuanghuanglian (Chinese:
Chinese Pharmacopoeia.[1]
The substance has been shown cytotoxic "against a clinical isolate of SARS-CoV-2".[1]
History
In July 2020, Su et al reported on an in vitro experiment of its effect on COVID-19.[1] Following the release of the report, which was in part supported by the Jack Ma Foundation,[1] there was an uptick in Shuanghuanglian sales.[2]
References
- ^ PMID 32737471.
- ^ Wee, Sui-Lee (5 February 2020). "In Coronavirus, China Weighs Benefits of Buffalo Horn and Other Remedies". The New York Times. Archived from the original on 6 February 2020. Retrieved 15 February 2020.